Employing traditional statistical methods and ML techniques, we provide an in‐depth analysis of the prognostic value of FOXC1 expression in stromal cells and pERK1‐2 expression in DLBCL tumor cells with established clinicopathological factors. Here, FOXC1 is linked to diffuse large B-cell lymphoma.